Prognostic value of a history of hypertension in 11483 patients with acute myocardial infarction treated with thrombolysis

被引:54
作者
Fresco, C
Avanzini, F
Bosi, S
Franzosi, MG
Maggioni, AP
Santoro, L
Bellanti, G
机构
[1] OC UDINE,IST CARDIOL,UDINE,ITALY
[2] IST RIC FARMACOL MARIO NEGRI,MILAN,ITALY
[3] OC RAVENNA,IST CARDIOL,RAVENNA,ITALY
关键词
arterial hypertension; acute myocardial infarction; prognostic factor;
D O I
10.1097/00004872-199606000-00010
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective To assess the prognostic value of a history of hypertension in patients with acute myocardial infarction (AMI) treated with thrombolysis. Design Retrospective adjusted analysis of outcome data of patients with AMI randomly allocated to treatment in a controlled study of alteplase versus streptokinase and heparin versus no heparin. Setting A highly representative sample (about 90%) of Italian Coronary Care Units. Patients Patients with (n = 3306) and without (n = 7406) a history of treated hypertension. Main outcome measures Morbidity and mortality during hospital stay and the next 6 months. Results Patients with a history of hypertension had a significantly higher mortality, both in hospital and during the next 6 months. The difference persisted also after a multivariate analysis including all major prognostic factors for in-hospital and 6-month mortality, respectively. Left ventricular failure and recurrent ischaemic events (angina and re-infarction) were also significantly more frequent in hypertensives both during their hospital stay and during follow-up study. Conclusions A history of hypertension is a negative independent prognostic factor after acute myocardial infarction treated with thrombolysis.
引用
收藏
页码:743 / 750
页数:8
相关论文
共 33 条
[1]  
[Anonymous], 1990, Lancet, V336, P65
[2]  
BIGGER JT, 1978, AM J CARDIOL, V42, P202, DOI 10.1016/0002-9149(78)90901-3
[3]  
CLEEMPOEL H, 1988, BRIT HEART J, V60, P98
[4]   BLOOD-PRESSURE, STROKE, AND CORONARY HEART-DISEASE .2. SHORT-TERM REDUCTIONS IN BLOOD-PRESSURE - OVERVIEW OF RANDOMIZED DRUG TRIALS IN THEIR EPIDEMIOLOGIC CONTEXT [J].
COLLINS, R ;
PETO, R ;
MACMAHON, S ;
HEBERT, P ;
FIEBACH, NH ;
EBERLEIN, KA ;
GODWIN, J ;
QIZILBASH, N ;
TAYLOR, JO ;
HENNEKENS, CH .
LANCET, 1990, 335 (8693) :827-838
[5]  
CRUICKSHANK JM, 1987, LANCET, V1, P581
[6]   RELATION OF LOW DIASTOLIC BLOOD-PRESSURE TO CORONARY HEART-DISEASE DEATH IN PRESENCE OF MYOCARDIAL-INFARCTION - THE FRAMINGHAM-STUDY [J].
DAGOSTINO, RB ;
BELANGER, AJ ;
KANNEL, WB ;
CRUICKSHANK, JM .
BRITISH MEDICAL JOURNAL, 1991, 303 (6799) :385-389
[7]  
De Martini M, 1990, G Ital Cardiol, V20, P215
[8]   THE J-CURVE PHENOMENON AND THE TREATMENT OF HYPERTENSION - IS THERE A POINT BEYOND WHICH PRESSURE REDUCTION IS DANGEROUS [J].
FARNETT, L ;
MULROW, CD ;
LINN, WD ;
LUCEY, CR ;
TULEY, MR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (04) :489-495
[9]  
GRECO R, 1984, Giornale Italiano di Cardiologia, V14, P1015
[10]   RECENT-EVIDENCE ON DRUG-THERAPY OF MILD TO MODERATE HYPERTENSION AND DECREASED RISK OF CORONARY HEART-DISEASE [J].
HEBERT, PR ;
MOSER, M ;
MAYER, J ;
Glynn, RJ ;
HENNEKENS, CH .
ARCHIVES OF INTERNAL MEDICINE, 1993, 153 (05) :578-581